CPB vs RXRX · P/E 12, rev $10.25B vs rev $58.8M
Campbell’s Co (CPB) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
Campbell’s Co (CPB) is a packaged foods company listed on US.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported CPB revenue for 2025-08-03 was $10.25B. Net income was $602.0M. Revenue was up 6.4% from 2024-07-28 to 2025-08-03. CPB currently screens at market cap $6.46B and trailing P/E 11.8.
Latest reported RXRX revenue for 2024-12-31 was $58.8M. Net income was -$463.7M. Revenue was up 32.0% from 2023-12-31 to 2024-12-31. RXRX currently screens at market cap $1.75B.
CPB currently screens at market cap $6.46B and trailing P/E 11.8. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the CPB and RXRX stock pages for the full models.
Not investment advice.